Actigall is a medication containing ursodeoxycholic acid that is used primarily to dissolve cholesterol gallstones and to treat certain liver disorders. It works by decreasing the production of cholesterol in the liver and by promoting the expulsion of cholesterol into the bile. The drug increases the solubility of cholesterol in bile, which prevents the formation of solid gallstone crystals. Actigall also modulates the immune response in the bile duct, reducing inflammation associated with some liver conditions. By altering the composition of bile, it facilitates the gradual dissolution of existing gallstones over time. The therapeutic effect is achieved through a gradual reduction of cholesterol saturation, leading to stone shrinkage and eventual clearance. Overall Actigall provides a non-surgical option for selected patients with cholesterol gallstones or specific hepatic diseases.

Actigall is a prescription medication used primarily to dissolve small cholesterol gallstones. Its pharmacological property is that it accelerates bile acid synthesis and promotes cholesterol solubilization in the gallbladder. The drug functions by activating the nuclear receptor fxr which increases bile flow and reduces cholesterol saturation. It also exhibits anti-inflammatory effects that help protect liver cells from injury. Through these actions the medication lowers cholesterol saturation index and facilitates gradual stone dissolution. Clinical use targets patients with radiolucent stones who are candidates for non-surgical management. The overall mechanism involves modulation of bile composition and enhanced gallbladder motility to achieve therapeutic stone clearance.

Actigall may cause diarrhea in some patients as a common side effect. Nausea and mild abdominal discomfort are also reported frequently. Some individuals experience mild constipation or changes in bowel habits. Headache and dizziness can occur but are usually transient. Fatigue is occasionally observed during treatment. Elevated liver enzyme levels have been noted in routine monitoring. Skin rash or itching may appear as uncommon skin reactions. Most side effects are mild and resolve without medical intervention.

Diarrhea may occur as a common side effect. Nausea can be experienced by some patients. Abdominal pain sometimes develops during treatment. Constipation is also reported occasionally. Headache may appear in certain individuals. Dizziness sometimes accompanies the therapy. Fatigue may be observed in a minority of users. Skin rash can develop in some cases.